Navigation Links
Aethlon Medical Note: Marc Robins Joins the Aethlon Team

SAN DIEGO, April 25, 2012 /PRNewswire/ -- Aethlon Medical, Inc. (OTCBB: AEMD), today released the following note authored by its Chairman and CEO, Jim Joyce.


Aethlon Medical was originally formed to advance a medical device technology that targeted the removal of harmful metals from circulation.  At the time, our strategy to treat infectious disease was a mere seed of thought and we certainly didn't envision the opportunities that would emerge in cancer and sepsis.  Since those early days, Marc Robins has witnessed both the setbacks and advances in our quest to create innovative therapies to combat life-threatening conditions.

I am pleased to advise you that Marc has agreed to work with us to expand the awareness of our endeavors within the financial and medical community.  Additionally, he will provide our shareholders with an additional channel of communication.  Marc's unique understanding of medical technology (including the medical devices in our therapeutic pipeline) and the financial markets will help to ensure our message is properly communicated.  He is also a passionate AEMD shareholder with 35 years of experience in discovering and investing in micro-cap medical technology organizations.  Marc was a "Special Situation" columnist at FORBES magazine, the founding publisher of the The Red Chip Review, an analyst at E.F. Hutton, and a principal at The Robins Group, LLC, an institutional investment banking firm that once managed a financing that helped us advance clinical programs. Marc can be reached at (877) 276-2467 or by email at

About Aethlon Medical

The Aethlon Medical mission is to create innovative medical devices that address unmet medical needs in cancer, infectious disease, and other life-threatening conditions. Our Aethlon ADAPT™ System is a revenue-stage technology platform that provides the basis for a new class of therapeutics that target the selective removal of disease enabling particles from the entire circulatory system. The Aethlon ADAPT™ product pipeline includes the Aethlon Hemopurifier® to address infectious disease and cancer; HER2osome™ to target HER2+ breast cancer, and a medical device being developed under a contract with the Defense Advanced Research Projects Agency (DARPA) that would reduce the incidence of sepsis in combat-injured soldiers and civilians. For more information, please visit


James A. Joyce
Chairman and CEO
858.459.7800 x301

Jim Frakes
Chief Financial Officer
858.459.7800 x300

John P. Salvador
Director, Communications
858.459.7800 x307

SOURCE Aethlon Medical, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Aethlon Medical Note: An Unprecedented Data Point, The Single-Treatment Capture of Hepatitis C Virus (HCV) by the Aethlon Hemopurifier®
2. Aethlon Medical Reports Immediate and Rapid Virologic Responses in Hepatitis C (HCV) Patients Receiving Hemopurifier® Treatment Protocol
3. Aethlon Medical Establishes Sepsis & Inflammation Scientific Advisory Board
4. Aethlon Medical Discloses Availability of the Biotech Showcase™ 2012 Presentation
5. Aethlon Medical Announces Biotech Showcase™ 2012 Presentation
6. Aethlon Medical Announces Approval and Initiation of Cancer Research Study to Target Tumor-Secreted Exosomes
7. Aethlon Medical Releases Shareholder Letter
8. Aethlon Medical to Present at IN3 Medical Innovation Summit on October 27th
9. Aethlon Medical Announces Availability of its Exosome Detection Assay to the Research Community
10. Aethlon Medical Announces Hemopurifier® and HER2osome™ Cancer Therapy Presentation at Exosomes and Microvesicles 2011
11. "A Medical Device Strategy To Inhibit HER2+ Breast Cancer Progression" Released by Aethlon Medical, Inc.
Post Your Comments:
(Date:11/24/2015)... Medical has developed specialty tubing for an inexpensive, portable mini-lab ... Africa and Asia ... diagnosis is important to treat those affected and to effectively ... of a portable mini-lab or "lab on a chip", medically-trained ... and perform rapid testing for HIV. They do this by ...
(Date:11/24/2015)... DIEGO , Nov. 24, 2015   Mast ... company leveraging its molecular adhesion and sealant technology (MAST) ... heart failure and stroke, today announced that the Company,s ... present at the Piper Jaffray 27 th Annual ... Eastern Time at the New York Palace hotel in ...
(Date:11/24/2015)... 2015  Depomed, Inc. (NASDAQ: DEPO ) today announced that ... month of December. Date: Wednesday, December 2, 2015 ... --> Date: Wednesday, December 2, 2015 ... --> Piper Jaffray 27th Annual Healthcare Conference ... Location: New York, New York ...
Breaking Medicine Technology:
(Date:11/24/2015)... PLAINSBORO, N.J. (PRWEB) , ... November 24, 2015 ... ... experts will gather to share their knowledge and experiences at a live taping ... during the Ruesch Center for the Cure of Gastrointestinal Cancers 2015 Symposium at ...
(Date:11/24/2015)... ... November 24, 2015 , ... With Thanksgiving right around the corner, holiday travel ... help protect your family and vehicle. , According to the National Highway Traffic Safety ... Amica is sharing the following safety tips from the NHTSA: , ...
(Date:11/24/2015)... ... November 24, 2015 , ... Chiropractic student Katie Benson received ... in Overland Park, Kansas. Benson, a fifth-trimester student in the university’s College of ... on October 16. , “Katie is very excited and greatly appreciative to receive ...
(Date:11/24/2015)... MA (PRWEB) , ... November 24, 2015 , ... ... Henry Ford and Detroit Taught Me about Reinvention and Diversity by Nancy M. ... Watching people suffer, with hospitals failing to adequately address the needs of patients and ...
(Date:11/24/2015)... IL (PRWEB) , ... November 24, 2015 , ... All her life, Don Peck’s mother ... Even her obituary said she might have been. After a 25-year search for information, ... voyager with whom she shared a last name. Turns out, it was Don’s father ...
Breaking Medicine News(10 mins):